NASDAQ: RADX
Radiopharm Theranostics Ltd Stock Ownership - Who owns Radiopharm Theranostics?

Insider buying vs selling

Have Radiopharm Theranostics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RADX insiders and whales buy or sell their stock.

RADX Shareholders

What type of owners hold Radiopharm Theranostics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paul Hopper4.17%147,721,428$240.05MInsider
Riccardo Canevari0.64%22,679,986$36.85MInsider
Ian Lawrence Turner0.28%9,985,292$16.23MInsider
Hester Denise Larkin0.02%644,247$1.05MInsider
Stonep0.00%102,000$165.75kInstitution
Stonepine Capital Management LLC0.00%51,000$82.88kInstitution
Aaron James Laurita0.00%26,357$42.83kInsider
Hsbc Holdings PLC0.00%62$100.75Institution
Hsbcho0.00%62$100.75Institution
Hsbc Holdings PLC 10.00%62$100.75Institution

1 of 2

RADX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RADX0.00%5.11%
CMMB0.00%2.89%Net BuyingNet Selling
PLRZ0.01%5.29%Net Selling
KTTA0.05%38.98%Net Buying
LPCN0.04%90.51%Net Buying

Radiopharm Theranostics Stock Ownership FAQ

Who owns Radiopharm Theranostics?

Radiopharm Theranostics (NASDAQ: RADX) is owned by 0.00% institutional shareholders, 5.11% Radiopharm Theranostics insiders, and 94.89% retail investors. Paul Hopper is the largest individual Radiopharm Theranostics shareholder, owning 147.72M shares representing 4.17% of the company. Paul Hopper's Radiopharm Theranostics shares are currently valued at $232.22M.

If you're new to stock investing, here's how to buy Radiopharm Theranostics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.